We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$348M
AUM Growth
+$51.1M
Cap. Flow
+$11.6M
Cap. Flow %
3.35%
Top 10 Hldgs %
32.79%
Holding
156
New
12
Increased
53
Reduced
49
Closed
4

Top Buys

Rank Stock Value
1
VTV icon
Vanguard Morningstar Value ETF
VTV
+$1.63M
2
EW icon
Edwards Lifesciences
EW
+$1.32M
3
MSFT icon
Microsoft
MSFT
+$1.15M
4
SCHP icon
Schwab US TIPS ETF
SCHP
+$881K
5
TMO icon
Thermo Fisher Scientific
TMO
+$849K

Top Sells

Rank Stock Value
1
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
+$459K
2
EPR icon
EPR Properties
EPR
+$403K
3
GFF icon
Griffon
GFF
+$258K
4
SPLK
Splunk Inc
SPLK
+$207K
5
SPGI icon
S&P Global
SPGI
+$206K

Sector Composition

Rank Sector Weight
1 Healthcare 17.86%
2 Technology 13.26%
3 Consumer Staples 11.19%
4 Financials 10.19%
5 Communication Services 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHM icon
26
Schwab US Mid-Cap ETF
SCHM
$15B
$4.13M 1.19%
181,593
+3,720
+2% +$77.6K
ABBV icon
27
AbbVie
ABBV
$435B
$4.05M 1.17%
37,806
+676
+2% +$65K
ABT icon
28
Abbott
ABT
$183B
$3.7M 1.07%
33,817
-250
-0.7% -$27.2K
MDLZ icon
29
Mondelez International
MDLZ
$79.9B
$3.61M 1.04%
61,695
-200
-0.3% -$11.4K
JPM icon
30
JPMorgan Chase
JPM
$955B
$3.59M 1.03%
28,259
-129
-0.5% -$14.4K
TFC icon
31
Truist Financial
TFC
$64.6B
$3.44M 0.99%
71,748
+5,712
+9% +$259K
V icon
32
Visa
V
$688B
$3.38M 0.97%
15,460
+1,532
+11% +$314K
CTSH icon
33
Cognizant
CTSH
$25.1B
$3.31M 0.95%
40,422
-1,600
-4% -$122K
BAX icon
34
Baxter International
BAX
$14.1B
$3.27M 0.94%
40,787
+875
+2% +$69.3K
STZ icon
35
Constellation Brands
STZ
$22.3B
$3.08M 0.89%
14,078
+100
+0.7% +$19.7K
SCHW
36
Charles Schwab
SCHW
$188B
$3.01M 0.87%
56,791
+250
+0.4% +$11.3K
T icon
37
AT&T
T
$158B
$2.92M 0.84%
134,247
-1,291
-1% -$27.8K
CERN
38
DELISTED
Cerner Corp
CERN
$2.69M 0.77%
34,283
-344
-1% -$25.5K
EMR icon
39
Emerson Electric
EMR
$91B
$2.68M 0.77%
33,339
-500
-1% -$37.2K
AMZN icon
40
Amazon
AMZN
$2.94T
$2.67M 0.77%
16,420
-20
-0.1% -$3.19K
IBM icon
41
IBM
IBM
$222B
$2.67M 0.77%
22,221
-557
-2% -$64.4K
SYY icon
42
Sysco
SYY
$40.3B
$2.55M 0.73%
34,375
-300
-0.9% -$20.6K
MCD icon
43
McDonald's
MCD
$195B
$2.55M 0.73%
11,871
-50
-0.4% -$10.9K
DGX icon
44
Quest Diagnostics
DGX
$26B
$2.5M 0.72%
20,950
– –
NVO
45
Novo Nordisk
NVO
$197B
$2.47M 0.71%
70,828
+100
+0.1% +$3.46K
MMM icon
46
3M
MMM
$93.9B
$2.45M 0.7%
16,742
+168
+1% +$23.8K
GM icon
47
General Motors
GM
$78.2B
$2.3M 0.66%
55,200
– –
GSK icon
48
GSK
GSK
$103B
$2.23M 0.64%
48,554
+2,110
+5% +$96.9K
EW icon
49
Edwards Lifesciences
EW
$51.2B
$2.21M 0.64%
24,260
+15,870
+189% +$1.32M
KO icon
50
Coca-Cola
KO
$374B
$2.2M 0.63%
40,057
-395
-1% -$20.4K
1
2
3 4 5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
DWA
Dorsey Wright & Associates Pasadena, California $807M AUM 65.46% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Kavar Capital Partners Group's Q4 2020 Portfolio in Review

As of Q4 2020, Kavar Capital Partners Group held 156 positions worth $348M, up 17% from $297M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Kavar Capital Partners Group deployed $11.6M of net new capital in Q4 2020, opening 12 new positions and adding to 53 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 14,484 shares worth $1.72M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Griffon, an estimated $258K trimmed.

  • Kavar Capital Partners Group's largest Q4 2020 buy was Vanguard Morningstar Value ETF: 14,484 shares worth $1.72M.
  • Kavar Capital Partners Group added most to Edwards Lifesciences in Q4 2020, an estimated $1.32M increase.
  • Kavar Capital Partners Group's biggest Q4 2020 reduction was Griffon, cutting an estimated $258K.
  • Kavar Capital Partners Group fully exited Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2020, selling an estimated $459K.
  • Kavar Capital Partners Group's ten largest holdings make up 33% of its $348M portfolio in Q4 2020.
  • Kavar Capital Partners Group opened 12 new positions and closed 4 in Q4 2020.
  • Kavar Capital Partners Group's portfolio value rose 17% quarter-over-quarter to $348M.

Based on Kavar Capital Partners Group's 13F filing for Q4 2020, filed 5 Feb 2021.